Loerrach, Germany

Roland Brugger

This inventor holds 2 USPTO granted patents. Top assignees: Dsm IP Assets B.v., Dsm Nutritional Products Inc.. Active years: 2004-2005.


% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roland Brugger: Innovator in Carotenoid Research

Introduction

Roland Brugger is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of carotenoids. With a total of 2 patents, his work has implications in diagnostics and vitamin A synthesis.

Latest Patents

Brugger's latest patents include innovations related to β,β-carotene 15,15'-monooxygenases. These patents disclose nucleic acid sequences coding for proteins with β,β-carotene 15,15'-monooxygenase activity. They also detail their uses in diagnostics, vitamin A synthesis, and methods for introducing the β,β-carotene 15,15'-monooxygenase cDNA into host cells. Another significant patent involves β,β-carotene 15,15'-dioxygenases, which also includes nucleic acid sequences coding for proteins with enzyme activity and their applications in similar fields.

Career Highlights

Throughout his career, Brugger has worked with prominent companies such as DSM IP Assets B.V. and DSM Nutritional Products Inc. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Brugger has collaborated with notable colleagues, including Wolf-Dietrich Woggon and Adrian Wyss. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Roland Brugger's work in carotenoid research exemplifies innovation in biochemistry. His patents and collaborations highlight his commitment to advancing scientific knowledge and practical applications in health and nutrition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…